Mckesson Medical-Surgical Inc. Corporate Office recalls
5 notices naming Mckesson Medical-Surgical Inc. Corporate Office as the recalling firm, since December 18, 2024. A notice covers specific products and lots, not every product of the firm.
Hazard and remedy text is quoted from the agency, unedited. The tag names the kind of risk with a word from that text. Every notice links to its official page.
Mckesson Medical-Surgical Inc. Corporate Office: Clearview Strep A Exact II Dipstick Respiratory Kit
Hazard (FDA): Due to a classification error in the inventory management system, specific medical devices were shipped to customers that did not have the requisite license to purchase such devices.
FDAMedical devices
Mckesson Medical-Surgical Inc. Corporate Office: PROLIA and 2 more
Hazard (FDA): CGMP Deviations; potential temperature excursions due to transit delays
FDAMedicines
Mckesson Medical-Surgical Inc. Corporate Office: ABBOTT RAPID DX N AMERICA LLC MULTI ANALYTE LVL1&2250UL CHOLS CONTROL and 31 more
Hazard (FDA): transit delays of certain cold chain products due to severe thunderstorms which may caused the products to be stored outside the recommended labeled storage conditions. This failure could increase the probability of an…
FDAMedical devices
Mckesson Medical-Surgical Inc. Corporate Office: Medroxyprogesterone Acetate Injectable Suspension and 1 more
Hazard (FDA): Severe thunderstorms caused transit delays of certain cold chain products that were shipped on 02-Apr-2025 and delivered after the 48-hours specified delivery time, on 07-Apr-2025 and 08-Apr-2025. The affected products…
FDAMedicines
Mckesson Medical-Surgical Inc. Corporate Office: Hylenex recombinant
Hazard (FDA): cGMP Deviations: Temperature excursion
FDAMedicines